KLSE (MYR): TMCLIFE (0101)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.675
Today's Change
-0.015 (2.17%)
Day's Change
0.67 - 0.69
Trading Volume
1,296,400
Market Cap
1,176 Million
NOSH
1,742 Million
Latest Quarter
31-Dec-2023 [#2]
Announcement Date
02-Feb-2024
Next Quarter
31-Mar-2024
Est. Ann. Date
23-May-2024
Est. Ann. Due Date
30-May-2024
QoQ | YoY
-4.07% | 164.55%
Revenue | NP to SH
352,453.000 | 57,203.000
RPS | P/RPS
20.23 Cent | 3.34
EPS | P/E | EY
3.28 Cent | 20.55 | 4.87%
DPS | DY | Payout %
0.84 Cent | 1.24% | 25.58%
NAPS | P/NAPS
0.50 | 1.35
QoQ | YoY
18.75% | 35.69%
NP Margin | ROE
16.23% | 6.57%
F.Y. | Ann. Date
31-Dec-2023 | 02-Feb-2024
Latest Audited Result
30-Jun-2023
Announcement Date
04-Oct-2023
Next Audited Result
30-Jun-2024
Est. Ann. Date
04-Oct-2024
Est. Ann. Due Date
27-Dec-2024
Revenue | NP to SH
311,443.000 | 39,257.000
RPS | P/RPS
17.88 Cent | 3.78
EPS | P/E | EY
2.25 Cent | 29.95 | 3.34%
DPS | DY | Payout %
0.84 Cent | 1.24% | 37.27%
NAPS | P/NAPS
0.49 | 1.38
YoY
-5.15%
NP Margin | ROE
12.60% | 4.60%
F.Y. | Ann. Date
30-Jun-2023 | 22-Aug-2023
Revenue | NP to SH
372,442.000 | 59,328.000
RPS | P/RPS
21.38 Cent | 3.16
EPS | P/E | EY
3.40 Cent | 19.82 | 5.05%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-2.03% | 153.15%
NP Margin | ROE
15.93% | 6.81%
F.Y. | Ann. Date
31-Dec-2023 | 02-Feb-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Dividend Years | 1 / 4 | 25.00% | 2 / 8 | 25.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | 1.66% | 1.47% | ||
Average Net Profit Margin | 16.26% | 15.72% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Total Positive Profit Years | 5 / 5 | 100.00% | 9 / 10 | 90.00% |
Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 5 / 10 | 50.00% |
Continuous Quarters Of Profit Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
Total Dividend Years | 5 / 5 | 100.00% | 9 / 10 | 90.00% |
Continuous Quarters Of Dividend | 5 / 5 | 100.00% | 5 / 10 | 50.00% |
Continuous Quarters Of Dividend Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Continuous Quarters Of Adjusted Dps Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Average ROE | 3.53% | 3.23% | ||
Average Net Profit Margin | 12.54% | 11.97% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 352,453 | 372,442 | 311,443 | 169,006 | 220,925 |
NP to SH | 57,203 | 59,328 | 39,257 | 22,704 | 28,454 |
Dividend | 14,631 | 0 | 14,631 | 3,995 | 5,955 |
Adjusted EPS | 3.28 | 3.40 | 2.25 | 1.30 | 1.63 |
Adjusted DPS | 0.84 | 0.00 | 0.84 | 0.23 | 0.34 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | 1.46% | 27.87% | 28.24% | 6.43% | 19.18% |
NP to Owner | -4.07% | 164.55% | 153.15% | 1.56% | 16.94% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | -4.60% | 159.38% | 153.73% | 1.22% | 16.29% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 13.17% | 59.54% | 108.54% | 19.59% | 68.58% | 120.37% | 27.76% | 40.97% | 84.28% |
NP to Owner | 45.71% | 101.04% | 151.94% | 51.13% | 108.50% | 161.30% | -5.15% | 37.97% | 72.90% |
Dividend | 0.00% | 145.68% | 266.22% | 0.00% | 0.00% | 0.00% | 200.00% | 145.68% | 266.22% |
Adjusted EPS | 45.78% | 100.91% | 151.73% | 51.11% | 108.26% | 160.94% | -5.46% | 37.82% | 72.68% |
Adjusted DPS | 0.00% | 145.68% | 266.22% | 0.00% | 0.00% | 0.00% | 200.00% | 145.68% | 266.22% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
I invest since year 2012. For me no entry point but invest regularly if possible. Long term investment. Trade at own risk ya ~.~
2021-11-23 15:40
results will be better and better only....with new wing opening, more bed capacity, more revenue and profit
2022-02-10 13:09
New wing started to contribute to the financial result. As time goes, significant improvement will show very soon.
2022-08-24 07:14
Less men more share then? Contrarian approach? Perhaps another takeover target.
2023-12-13 23:10
Bot enough, start to promote.
https://klse.i3investor.com/web/blog/detail/sinchew_company_story/2024-01-01-story-h-211423465
2024-01-01 22:51
Alpha IVF listing with RM1.5 billion valuation soon,i think TMC was very much undervalued at current price.
1 month ago
Beside IVF business which is recovering strongly,TMC also owned Thomson Hospital Kota Damansara,a premium hospital with 336 operating bed currently and maximum capacity of 554 bed when fully utilized the new wing by 2026.
1 month ago
my personal opinion, TMC should worth around RM2 .0 to 2.4 billion based on FY2024 EV/Ebitda of 18-20x,the target valuation consider quite conservative given the rapid capacity expansion and high growth potential in next 5 year.
1 month ago
Colgate
PRAY HARD < ROCKET UP on the way
2021-11-10 19:17